Financial Calendar

Year-end report 2018	February 26, 2019
Q1 report 2019	May 23, 2019
Annual General Meeting, Gothenburg, Sweden	May 23, 2019
Q2 report 2019	August 22, 2019
Q3 report 2019	November 13, 2019

Share information
Analysts
Company Presentation
IPO
Financial Reports
Financial Calendar
IR Contact and Certified Adviser
Share owners

About Isofol

Isofol Medical AB (publ) is a biotech company within the field of oncology developing arfolitixorin, primarily as a treatment for advanced colorectal cancer and as a rescue drug after high-dose methotrexate treatment in osteosarcoma (bone cancer).

Contact

Isofol Medical AB (publ)
Biotech Center, Arvid Wallgrens Backe 20
SE-413 46 Gothenburg
Sweden

Phone: +46 (0)31 7972280
E-mail: info@isofolmedical.com

Newsletter and Privacy Policy

Sign up here to receive information and news and agree to Isofol’s processing of your personal data according to the company’s Integrity.
Isofol´s Integrity Policy (general)
Isofol´s Integrity Policy (clinical studies)

Isofol´s Glossary